Overview

Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients

Status:
Recruiting
Trial end date:
2029-09-01
Target enrollment:
0
Participant gender:
All
Summary
The objectives are to compare the results of the Gastric By-Pass (GBP) to that of optimized medical therapy in patients with obesity and poorly controlled type 2 diabetes in terms of mortality, weight loss, glycemic control, quality of life, cost, cost-effectiveness and cost utility of these two strategies.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Lille
Criteria
Inclusion Criteria:

- Type 2 diabetes mellitus with HbA1c > 7.5 %

- Body mass index > 35 and < 50 kg/m2

- Candidate for Gastric By-Pass

- Treatment with GLP1 (glucagon-like peptide) analogue or insulin

Exclusion Criteria:

- Contraindication to bariatric surgery

- Pregnancy

- Affiliation of health care assurance

- Psychiatric disorders